Published :
Tables : 62
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3289
Drug Eluting Stents Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027. Rising geriatric population, unhealthy food habits, sedentary lifestyle and a lack of exercise are some of the key factors driving the drug eluting stents market growth. Additionally, the drastic shift to DES from angioplasty for treating atherosclerosis across the world has significantly boosted the market growth. Furthermore, the DS technique is minimally invasive which shall propel the proliferation of the market. On the other hand, the risks in implementing DES technique such as endothelial tissues regrowth disruption and stent thrombosis shall restrain the proliferation of the market. Market Segmentation: By Product • Polymer-Based Coating • Polymer-Free Coatings By Application • Coronary Artery Disease • Peripheral Artery Disease By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into product, application and region. The product segment is bifurcated into polymer-based coatings and polymer free coatings. The polymer-based coatings is categorised into non-biodegradable polymer based and biodegradable polymer based. The polymer free coatings is segregated into micro structured surface, micro porous surface, nano porous surface and slotted tubular surface. The microporous surface segment held the largest drug eluting stents market share during the forecasted timeframe owing to the increased acceptance of DES due to lower rate of in-stent restenosis. The nano porous segment is predicted to lead the market owing to the high drug loading capacity of these products. The application segment is categorised into peripheral artery disease and coronary artery disease. The coronary artery disease segment is anticipated to dominate the market owing to the increased occurrence of appalling diseases like arrhythmia which has boosted the insistence of drug eluting stents over the forecast period. Regional Analysis: The North America region expected to dominate the global market, and this can be credited to stringencies in guidelines for medical device approval and manufacturing. Additionally, improved reimbursement coverage along with high rate of incidence of artery diseases has bolstered the proliferation of the market. Competitive Landscape: Some of the key market players are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global drug eluting stents market by product, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising geriatric population, unhealthy food habits, sedentary lifestyle and a lack of exercise are some of the key factors driving the drug eluting stents market growth. Additionally, the drastic shift to DES from angioplasty for treating atherosclerosis across the world has significantly boosted the market growth. Furthermore, the DS technique is minimally invasive which shall propel the proliferation of the market. On the other hand, the risks in implementing DES technique such as endothelial tissues regrowth disruption and stent thrombosis shall restrain the proliferation of the market.
Market Segmentation:
By Product • Polymer-Based Coating • Polymer-Free Coatings By Application • Coronary Artery Disease • Peripheral Artery Disease By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into product, application and region. The product segment is bifurcated into polymer-based coatings and polymer free coatings. The polymer-based coatings is categorised into non-biodegradable polymer based and biodegradable polymer based. The polymer free coatings is segregated into micro structured surface, micro porous surface, nano porous surface and slotted tubular surface. The microporous surface segment held the largest drug eluting stents market share during the forecasted timeframe owing to the increased acceptance of DES due to lower rate of in-stent restenosis. The nano porous segment is predicted to lead the market owing to the high drug loading capacity of these products. The application segment is categorised into peripheral artery disease and coronary artery disease. The coronary artery disease segment is anticipated to dominate the market owing to the increased occurrence of appalling diseases like arrhythmia which has boosted the insistence of drug eluting stents over the forecast period.
Regional Analysis:
The North America region expected to dominate the global market, and this can be credited to stringencies in guidelines for medical device approval and manufacturing. Additionally, improved reimbursement coverage along with high rate of incidence of artery diseases has bolstered the proliferation of the market.
Competitive Landscape:
Some of the key market players are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global drug eluting stents market by product, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Drug Eluting Stents Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Polymer-Based Coating 7.1.1 Non-Biodegradable Polymer Based Coating 7.1.2 Biodegradable Polymer Based Coating 7.2 Polymer-Free Coatings 7.2.1 Micro Porous Surface 7.2.2 Micro Structured Surface 7.2.3 Slotted Tubular Surface 7.2.4 Nano porous Surface 8. Drug Eluting Stents Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Coronary Artery Disease 8.2 Peripheral Artery Disease 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Boston Scientific Corporation 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Medtronic 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 Abbott Laboratories 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Biosensors International Group 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Biotronik 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Lepu Medical Technology 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 Terumo Medical Corporation 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Cook Medical 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Shandong JW Medical Systems 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Stentys 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics